Beranda › Penyakit Radang Usus › Washington
Uji klinis Penyakit Radang Usus di Washington
10 studi untuk Penyakit Radang Usus mencari peserta di lokasi di Washington.
Kota di Washington
Teks studi resmi (Bahasa Inggris)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- University of Washington School Medicine, Seattle
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06598943A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 004, Seattle
- Site 019, Tacoma
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-021, Bellevue
- Site US-029, Tacoma
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07845487Familial Inflammatory Bowel Disease Early Risk
- Seattle Children's Hospital, Seattle
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 hingga 55 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07791862A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Seattle Children's Hospital, Seattle
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05509777Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Seattle Children's Hospital, Seattle
Menerima pesertaFase 4
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT05781152Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
- Seattle Children's Hospital, Seattle
Menerima pesertaStudi observasional
Usia 6 hingga 21 · Semua jenis kelamin · Diperbarui 24 Apr 2026 · NCT06315179A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Bellevue
- Mirador Therapeutics Selected Site, Silverdale
- Mirador Therapeutics Selected Site, Tacoma
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT07113522A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
- Liver institute Northwest, Seattle
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Okt 2025 · NCT06699121Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
- Seattle Children's Hospital, Seattle
Menerima peserta
Usia 8 hingga 21 · Semua jenis kelamin · Diperbarui 12 Jun 2025 · NCT06216899Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.